A ativina a em primigestas e multigestas: dosagem sérica e urinária em estudo prospectivo transversal

• Ano de defesa: 2022
• Autor(a) principal: Bruna Barbosa Coimbra Corlaite
• Tipo de documento: Dissertação
• Tipo de acesso: Acesso aberto
• Idioma: por
• Instituição de defesa: Universidade Federal de Minas Gerais; Brasil; MED - DEPARTAMENTO DE GINECOLOGIA OBSTETRÍCIA; MEDICINA - FACULDADE DE MEDICINA; Programa de Pós-Graduação em Saúde da Mulher; UFMG
• Palavras-chave em Português: Ativina a; Idade gestacional; Gestação; Primigesta; Urinálise; Receptores de Ativinas; Gravidez; Biomarcadores
• Link de acesso: http://hdl.handle.net/1843/47072

The aim of the present study was to investigate serum and urine levels of activin A in different moments of gestation, in primigravidae and in multigravidae, to understand whether these variables (biological sample and first gestation) affect activin A as a biomarker in pregnancy. We prospectively included 43 pairs of serum and urine samples from 25 women examined at different gestational ages (range 45 to 268 days). In the group of primigravidae (n = 16 samples from 9 participants), there was no significant change in serum activin A levels across gestation. Conversely, the group of multigravidae (n = 27 samples from 16 women) had higher serum activin A levels in the third trimester (2676 ± 840 pg/ml) compared to the first (583 ± 408 pg/ml) and second (1040 ± 384) trimestres (p = .025). Urine activin A concentrations did not differ between the two groups and did not change according to the gestation phase. There was no correlation between serum and urinary levels of activin A (r = 0.149, p = .359). These data suggest that activin A secretion may vary less during the first pregnancy, while urine activin A is unlikely to be a surrogate for the systemic levels of this hormone in pregnant women.